Besides, harmine was considered to be a potential candidate for Alzheimer’s disease therapy by inhibiting acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity [11]. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.